Leading CMO purchases multiple GMP scale twin-column units
Continuous chromatography technology now planned for production suites to give CMO a leading edge with new therapies at attractive cost point. Patented MCSGP will significantly increase yield of oligo and peptide production.
Previous Article
FDA purchases YMC technology Related Posts
April 28, 2025
J Preston, PhD, to present at TIDES in San Diego, May 19-22, 2025
Development of a Two-Step Chromatographic Process for the Purification of a Dual GIP / GLP-1 Receptor Agonist
April 25, 2025
Expanded Facilities and Capabilities at Insight Center in California
YMC America has invested in enhancing our West Coast capabilities with an upgraded Insight Center laboratory in Thousand Oaks, California! This expansion means more space, more cutting-edge chromatography equipment, and even greater capacity to support our partners. Our dedicated team
April 11, 2025
Shimadzu Visits YMC America
YMC America was pleased to recently host representatives from Shimadzu at our facility in Devens, MA. The visit provided a valuable opportunity for strategic discussion focused on potential cooperative programs between our organizations. Our CEO, Mark Dyment, met with the
